Prescription Drugs

February 22, 2023 | Controlled Substances, Harm Reduction, Innovative Initiatives, Naloxone, Opioid Antagonists, Opioids, Prescription Drugs, Public Health, Recovery, Substance Misuse, Treatments

In the beginning of 2022, the West Virginia Drug Intervention Institute, the West Virginia Collegiate Recovery Network, and Marshall University, a public research university in Huntington, West Virginia, launched an overdose prevention initiative on every public and private college campus in West Virginia. The program, entitled, “Be The One” focuses on opioid overdose prevention from a bystander’s perspective, encouraging students, staff, and faculty to “be the one” to save a life....

January 6, 2023 | Controlled Substances, Fact Sheets, Fentanyl, Kratom, Marijuana, Methamphetamine, Novel Psychoactive Substances, Opioids, Prescription Drugs, Stimulants, Substance Misuse, Synthetic Drugs

Millions of people throughout the world use social media platforms (or “apps”) providing an easy avenue to reach a large number of people. Legitimate businesses are not the only ones to use social media apps as a marketing tool. In recent years, drug dealers have turned to such apps to solicit buyers and arrange sales. This fact sheet examines the growing use of social media, by drug suppliers, to surreptitiously advertise to a wide audience, by using apps that offer encrypted or disappearing messages....

December 16, 2022 | Controlled Substances, Harm Reduction, Innovative Initiatives, Opioids, Prescription Drugs, Public Health, Recovery, Substance Misuse, Treatments

In October 2022, Wisconsin’s Department of Health Services (DHS), in conjunction with the state’s department of justice (DOJ) and the Office of Governor Tony Ever announced the launch of the Real Talks campaign to help address the rise in substance use in the state. In recent years, much like the rest of the country, Wisconsin has seen a sizable increase in opioid-related deaths. In fact, between 2018 and 2020, the number of opioid-related deaths increased by 46.7 percent. In addition, alcohol misuse continues to be a problem. Data from DHS indicates that adults in the state rank third in the United States for alcohol use. Real Talks Wisconsin is part of a series of DHS programs aimed at preventing and reducing substance use or abuse within the state. Real Talks discusses community prevention programs and encourages harm reduction programs, such as free access to emergency opioid antagonists....

July 14, 2022 | Alcohol, Controlled Substances, Fact Sheets, Harm Reduction, Opioids, Prescription Drugs, Public Health, Recovery, Substance Misuse, Treatments

Recovery residences provide a sober, safe, and healthy living environment that promotes recovery from alcohol and other drug use and associated problems. These residences are commonly referred to by a number of names, including sober living houses, sober living environments, and recovery homes, and their primary purpose is to provide a home-like environment for individuals in recovery from substance use disorder to help sustain that recovery....

July 14, 2022 | Controlled Substances, Law Enforcement, Legal & Legislative Research, Prescription Drugs, Public Safety

In this survey, the Legislative Analysis and Public Policy Association (LAPPA) examines the state-level legislative response to drugged driving. In Section I, it presents the existing laws on driving under the influence of drugs in the 50 states and the District of Columbia. Section II highlights a selection of additional resources for policymakers on drugged driving research and policy proposals in the United States. These resources include scientific studies, such as the latest research on the physiological effects of certain substances on drivers and the effectiveness of new testing methods and policy analysis, including recommendations from the U.S. Department of Justice on how to effectively detect and prosecute drugged driving. Together they illuminate the evolving landscape of drugged driving in the United States and the potential remedies that can keep Americans safe on the roads....

June 22, 2022 | Controlled Substances, Opioids, Prescription Drugs, Public Health, Recovery, Reports & Studies, Substance Misuse, Treatments

The COVID-19 pandemic created an unprecedented public health emergency throughout the world, prompting providers to turn to telehealth to provide necessary health care to patients at a distance. This paper analyzes the current state of telehealth services at the federal and state levels, as well as the benefits and limitations of telehealth technology use. It also offers public policy recommendations to improve telehealth services in the United States....

May 19, 2022 | Controlled Substances, Harm Reduction, Innovative Initiatives, Law Enforcement, Opioids, Prescription Drugs, Public Health, Recovery, Substance Misuse, Treatments

The restaurant industry has been particularly impacted by the opioid epidemic with, for example, ten percent of food service workers dying from opioid overdoses in the State of Delaware.[1] This sobering statistic prompted the Delaware Division of Public Health (DPH) to launch the Restaurant Accolade Program (the Program), which trains all restaurant staff and owners in the state on how to identify, respond to, and reverse an opioid overdose and helps food establishments draft policies that support employees and patrons with substance use disorders (SUDs). The Office of Health Crisis Response (OCHR) within DPH conducts the training and education....

March 28, 2022 | Controlled Substances, Criminal Justice, Drug Courts, Law Enforcement, Opioids, Prescription Drugs, Public Health, Public Safety, Recovery, Reports & Studies, Substance Misuse, Synthetic Drugs

In September 2021, Georgetown University Law Center convened an Opioid Litigation Summit. This convening brought together numerous experts to discuss legal, administrative, and programmatic strategies needed to optimize the impact of proceeds from the opioid litigation. The themes described in this brief emerged from the Summit and can be applied to the opioid litigation as well as future mass tort litigation to address public health crises....